“In situ endothelial modulation and transduction” strategy driven by biomimetic H2S delivery system for targeted repair of vascular injury
Biomaterials · 2026
DOI: 10.1016/j.biomaterials.2025.123774 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomaterials, 2026. Verfasst von Bin Gao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Neurosurgery Research Institute, The First Affiliated Hospital, Fujian Medical University, Fuzhou, 350005, Fujian, China;…. Hauptthemen laut MEDLINE: Endothelial Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Fujian Medical University, National Natural Science Foundation of China, Natural Science Foundation of Fujian Province.
Abstract (Originalsprache)
Vascular recanalization mediated by the interventional therapy can reduce cardio-cerebrovascular disease burden. However, its long-term outcomes are often undesired owing to (1) inevitable mechanical damage to the vasculature that triggers pathological remodeling, presented as local inflammation/oxidative stress, intimal hyperplasia, and delayed endothelial healing; and (2) long-term and frequent use of antiplatelet drugs, which increase bleeding risks. These challenges highlight the necessity for rapid vascular repair and minimizing dosing frequency, which are currently unmet due to the lack of a highly efficient delivery/therapy strategy. Herein, we formulated a damaged vascular endothelial-targeted hydrogen sulfide (H2S) nanomedicine, utilizing the endothelial cells (ECs) as a delivery destination rather than the traditional smooth muscle cells (SMCs) for overcoming drug delivery barriers. This drug targets the ECs, where it releases H2S in a sustained manner to promote endothelial regeneration and in situ transduce signaling from ECs for suppressing SMC-mediated intimal hyperplasia and reprogramming Mφ to inhibit local inflammation. A single dose of therapy achieved satisfactory vascular repair and safety within 28 days in the carotid artery injury model. This study provides a novel solution for vascular repair and advances the development of a drug delivery approach.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Neurosurgery Research Institute, The First Affiliated Hospital, Fujian Medical University, Fuzhou, 350005, Fujian, China; Fujian Provincial Institutes of Brain Disorders and Brain Sciences, T…
- School of Chemical Engineering and Technology, Hebei University of Technology, Tianjin, Tianjin, 300131, China.
Förderung
- Fujian Medical University
- National Natural Science Foundation of China
- Natural Science Foundation of Fujian Province
Zitieren
APA
Gao, B., Zhang, Y., Huang, X., Li, S., Niu, X., Kang, D., Lin, Y., & Yao, P. (2026). “In situ endothelial modulation and transduction” strategy driven by biomimetic H2S delivery system for targeted repair of vascular injury. Biomaterials. https://doi.org/10.1016/j.biomaterials.2025.123774
Vancouver
Gao B, Zhang Y, Huang X, Li S, Niu X, Kang D, et al. “In situ endothelial modulation and transduction” strategy driven by biomimetic H2S delivery system for targeted repair of vascular injury. Biomaterials. 2026. doi:10.1016/j.biomaterials.2025.123774
BibTeX
@article{Gao2026,
author = {Gao, Bin and Zhang, Yibin and Huang, Xiaofen and Li, Shengnan and Niu, Xuegang and Kang, Dezhi and Lin, Yuanxiang and Yao, Peisen},
title = {“In situ endothelial modulation and transduction” strategy driven by biomimetic H2S delivery system for targeted repair of vascular injury},
journal = {Biomaterials},
year = {2026},
doi = {10.1016/j.biomaterials.2025.123774}
}
EUVIMED